EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ATA 2015-2025 risk stratification transition: prognostic significance of N1b disease in papillary thyroid carcinoma with limited nodal burden

Ziqiang Wang, Yangyang Xie, Tingting Wang, Danwei Du, Xue Song iD

The Oncologist · 08.05.2026 · 31 (6)

DOI: 10.1093/oncolo/oyag186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 12.05.2026. Verfasst von Ziqiang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical Universit…. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Lymph Nodes, Thyroid Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Medical and Health Science and Technology Plan, Zhejiang Province Traditional Chinese Medicine Science and Technology, Hangzhou Health Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The ATA risk stratification system has evolved from the 2015 framework toward a more composite nodal risk assessment in the 2025 update. Whether low-volume lateral neck disease remains clinically meaningful is uncertain. We evaluated the prognostic significance of N1b vs N1a disease in papillary thyroid carcinoma (PTC) with ≤5 metastatic lymph nodes. Materials and Methods We identified 11 878 patients with PTC and N1a or N1b disease with ≤5 metastatic lymph nodes from the SEER database (2000-2022). One-to-one propensity score matching was performed. OS and CSS were assessed using Kaplan–Meier analysis, and CSD and OCD using cumulative incidence functions and Fine–Gray models.

Results

Among eligible patients, 9392 had N1a disease and 2486 had N1b disease. After matching, 2467 patients remained in each group. N1b was associated with significantly worse OS, CSS, and CSD in both unmatched and matched cohorts. In the matched cohort, 5-year CSD increased from 1.5% to 2.8%. On multivariable Fine–Gray analysis, N1b remained independently associated with higher CSD risk (SHR, 2.52; 95% CI, 1.85-3.43; P < .001). The adverse effect was more evident in patients with positive ETE, tumor diameter >2 cm, and older age.

Conclusion

Among patients with PTC and ≤5 metastatic lymph nodes, N1b retains independent adverse prognostic significance despite low nodal burden. Low-volume nodal disease should not be considered uniformly low risk when lateral neck involvement is present, particularly in patients with positive ETE, tumor diameter >2 cm, or older age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Cancer, PapillaryLymph NodesThyroid NeoplasmsHumansPrognosisFemaleMiddle AgedLymphatic MetastasisMaleAdultRisk AssessmentSEER ProgramAged

Stichwörter der Autor:innen

ATA risk stratificationN1b diseaseSEERcompeting-risk analysislow-volume nodal metastasespapillary thyroid carcinoma

Autor:innen und Institutionen

  • Department of Thyroid and Breast Surgery, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, 311000, China.
  • Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.
  • The Department of General Practice, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
  • Department of Anorectal, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310000, China.
  • Department of Respiratory and Critical Care Medicine, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310007, China.

ORCID-Profile: Xue Song

Förderung

  • Zhejiang Provincial Medical and Health Science and Technology Plan
  • Zhejiang Province Traditional Chinese Medicine Science and Technology
  • Hangzhou Health Science and Technology
  • the Basic Public Welfare Research Program of Wenzhou Science and Technology Bureau

Zitieren

APA

Wang, Z., Xie, Y., Wang, T., Du, D., & Song, X. (2026). ATA 2015-2025 risk stratification transition: prognostic significance of N1b disease in papillary thyroid carcinoma with limited nodal burden. The Oncologist, 31(6). https://doi.org/10.1093/oncolo/oyag186

Vancouver

Wang Z, Xie Y, Wang T, Du D, Song X. ATA 2015-2025 risk stratification transition: prognostic significance of N1b disease in papillary thyroid carcinoma with limited nodal burden. The Oncologist. 2026;31(6). doi:10.1093/oncolo/oyag186

BibTeX
@article{Wang2026,
  author = {Wang, Ziqiang and Xie, Yangyang and Wang, Tingting and Du, Danwei and Song, Xue},
  title = {ATA 2015-2025 risk stratification transition: prognostic significance of N1b disease in papillary thyroid carcinoma with limited nodal burden},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {6},
  doi = {10.1093/oncolo/oyag186}
}
Kostenlos starten →